Sara Karlovitch
Articles
Adjuvant Neratinib or T-DM1 Decreases Distant Recurrence Risk in HER2+ Early-Stage Breast Cancer
December 10, 2021
Article
The introduction of adjuvant approaches reduced the risk of disease recurrence in HER2-positive, early-stage breast cancer.
End-of-Life Discussions Reduce Patient Anxiety, Discomfort in Cancer Care
July 15, 2019
Article
Despite most wishing to die at home, nearly a third of patients with cancer die in the hospital. Goals-of-care discussions with nurses and other providers can help bring that number down.
Advertisement
Advertisement